Fylde and Wyre CCG Medicines Optimisation

Click each header to expand its content

Fylde and Wyre medicines RAG list

Application forms

Medicines commissioning policies

NameSizeHits
Actipatch for pain management 0.6 MB399
Albiglutide for type-2 diabetes mellitus 0.3 MB268
Alprostadil Cream For ED 0.3 MB308
Azelastine Fluticasone (Dymista) Nasal Spray 0.1 MB415
Bazedoxifene for oestrogen deficiency symptoms 0.3 MB246
Brimonidine For Erythema Of Rosacea 0.1 MB232
Brivaracetam for epilepsy 0.3 MB257
Budesonide multimatrix MMX 9mg prolonged release tablets 0.2 MB418
Certolizumab For Psoriatic Arthritis 0.1 MB203
Co-Proxamol For pain management 0.3 MB445
Co-trimoxazole for the prophylaxis of pneumocystis jirovecii (pneumocystis carinii) infections 0.3 MB272
Co-trimoxazole Prophylaxis of Primary and Secondary Spontaneous Bacterial Peritonitis (SBP) 0.1 MB354
Colesevelam (Cholestagel® ) For combination or monotherapy for familial hypercholesterolaemia 0.3 MB238
Colistimethate sodium/Colistin sulfomethate sodium (Colomycin® ) For non-Cystic Fibrosis in Patients with Bronchiectasis Colonised with Pseudomonas Aeruginosa 0.2 MB240
Conditions for which over the counter items should not routinely be prescribed in primary care 0.9 MB528
Daily selective serotonin re-uptake inhibitors (SSRIs) for the treatment of premature ejaculation (PE) 0.2 MB185
Dapoxetine for the treatment of premature ejaculation (PE) 0.2 MB192
Denosumab for GIO 0.2 MB220
Dulaglutide for the treatment of Type II Diabetes Mellitus in adults 0.3 MB308
Eflornithine-cream-for-facial-hirsutism 0.2 MB250
Eltrombopag For Thrombocytopenia In Hepatitis C 0.1 MB192
Eslicarbazepine For Focal Seizures 0.1 MB245
Evolocumab (Repatha SureClick® ) For prevention of cardiac events in patients with CHD and a history of ACS, in combination with a statin 0.1 MB205
Ferric Maltol 30mg Capsules in Adults for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease 0.3 MB217
Fluorouracil-5-cream-for-basal-cell-carcinomas 0.1 MB305
Guanfacine-for-ADHD 0.3 MB198
Imiquimod-5-cream-for-basal-cell-carcinomas 0.2 MB209
Insulin Degludec And Liraglutide 0.2 MB230
Insulin-Aspart-for-Diabetes-Mellitus 0.3 MB239
Insulin-Degludec-for-DM 0.3 MB213
Insulin-Detemir-for-DM 0.2 MB178
Insuline-Glargine-for-T1DM 0.3 MB201
Insuline-Glargine-for-T2DM 0.3 MB200
Invicorp-injection-for-erectile-dysfunction 0.3 MB442
Ivermectin-cream-for-rosacea 0.3 MB202
JIA Policy For Adults (Version 1.0) 0.2 MB207
Lamotrigine-for-trigeminal-neuralgia 0.3 MB207
Lamotrigine-for-trigeminal-neuralgia 2 0.3 MB221
Levonorgestrel 13.5mg IUD 0.3 MB187
Lidocaine Plasters For PHN 0.2 MB244
Lidocaine-plasters-for-unlicensed-indications 0.3 MB316
Liothyronine-for-refractory-hypothyroidism 0.2 MB255
Liraglutide-for-obesity 0.3 MB232
Lisdexamfetamine-for-ADHD-in-adults 0.3 MB423
Lisdexamfetamine-for-ADHD-update 0.3 MB253
Lurasidone-for-Schizophrenia 0.3 MB269
Magnaspartate For Hypomagnesaemia 0.3 MB1262
Metformin-for-reductionof-risk-or-delay-type-2-daibetes 0.2 MB184
Metformin-for-reductionof-risk-or-delay-type-2-daibetes 2 0.2 MB164
Midazolam-Epistatus-for-seizures 0.2 MB416
Opicapone-for-Parkinsons-disease-v2 0.5 MB251
Ospemifene for VVA 0.2 MB533
Oxycodone-Naloxone-for-Restless-legs 0.3 MB238
Paravit-CF-for-dietary-management-of-patients-with-cystic-fibrosis 0.2 MB1043
Patiromer-for-hyperkalaemia 0.3 MB206
Patiromer-for-hyperkalaemia 2 0.3 MB238
Phosphodiesterase Type-5 Inhibitors 0.2 MB209
Pitolisant-for-Narcolepsyv2 0.3 MB272
Policy On Brand Inhaler Prescribing 0.3 MB727
Probiotics And VSL 0.3 MB328
Relvar Ellipta for COPD and asthma in adults 63 KB205
Rituximab-for-AIHA 0.4 MB229
Rituximab-for-ITP 0.4 MB203
Safinamide-for-Parkinsons-disease 0.3 MB241
Second-generation-LA-antipsychotics 0.3 MB240
Secukinumab-for-Palmoplantar-psoriasis 0.3 MB202
Secukinumab-for-Palmoplantar-psoriasis 2 0.3 MB177
Semaglutide for type 2 DM 0.2 MB505
Silk Garments For Eczema And Dermatitis 0.2 MB195
Simbrinza for chronic open angle glaucoma 0.1 MB213
Sodium Oxybate for Narcolepsy with Cataplexy 0.3 MB277
Spironolactone For Acne 0.1 MB269
Subcutaneous Depot Medroxyprogesterone Acetate 0.1 MB208
Tadalafil daily 0.3 MB418
Tapentadol for neuropathic pain in non-palliative care 0.4 MB228
Tapentadol for non-specific pain 0.2 MB232
Testosterone For Female Sexual Dysfunction 0.1 MB287
Tiotropium For Asthma 0.2 MB186
Tocilizumab SC For RA 0.1 MB163
Trelegy inhaler for COPD 0.3 MB410
Trimbow inhaler for COPD 0.4 MB314
Trimbow-inhaler-for-COPD 0.4 MB6
Ulipristal acetate for uterine fibroids 0.5 MB200
Umeclidinium For COPD 0.2 MB220
Vedolizumab For Crohn's Disease 0.2 MB176
Vesomni For Benign Prostatic Hyperplasia 0.1 MB229
Vitamins (inc Renavit) For Dialysis 0.3 MB528
Waterproof Cast Cover Policy 0.1 MB686
Xonvea for nausea and vomiting in pregnancy 0.1 MB220

Medicines guidelines, information sheets, and shared care

Further medicines guidelines are available on Lancashire Medicines Management Group’s website.

Primary care rebate schemes

Primary care rebate schemes are contractual arrangements offered by pharmaceutical companies, or third party companies, which offer retrospective financial rebates to the CCG on GP prescribing expenditure for particular branded medicine(s). The availability of a scheme does not influence the inclusion of specific medicines in care pathways or formularies.

Current Primary Care Rebate Schemes in place:

  • Clenil Modulite (Beclometasone) – Started July 2019
  • Fencino (Fentanyl) – Started April 2016
  • Firmagon (Degarelix) – Started September 2016
  • Januvia (Sitagliptin) – Started September 2018
  • Lixiana (Edoxaban) – Started February 2018
  • Longtec (Oxycodone SR) – Started July 2019
  • Sereflo (Fluticasone / Salmeterol) – Started July 2019
  • Seretide (Fluticasone / Salmeterol) – Started April 2016
  • Xarelto (Rivaroxaban) – Started October 2019
  • Zoladex (Goserelin) – Started January 2019

Fact and advice sheets

Inhaler Techniques

Inhaler technique videos are available to view online.

Last updated on 18 December 2019 at 11:14 by Senior communications and engagement officer N